Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness.
It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Company profile from EODHD, stored Oct 26, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 7, 2026 | — | — | — | -$1.6M | -$1.5M |
| Mar 2026filed May 8, 2026 | — | — | — | -$1.5M | -$1.4M |
| Dec 2025filed Mar 20, 2026 | $3.0K | 0.0% | 66.9% | -$1.9M | -$1.9M |
| Sep 2025filed Nov 7, 2025 | — | — | — | -$1.3M | -$1.2M |
| Jun 2025filed Aug 8, 2025 | — | — | — | -$1.3M | -$1.2M |
| Mar 2025filed May 9, 2025 | $3.0K | 0.0% | 60.0% | -$1.7M | -$1.6M |
| Dec 2024filed Mar 14, 2025 | $3.0K | 0.0% | 60.0% | -$1.9M | -$1.9M |
| Sep 2024filed Nov 8, 2024 | — | — | — | -$1.1M | -$1.0M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 20, 2026 | $6.0K | -45.5% | 63.4% | -$6.1M | -$6.0M |
| Dec 2024filed Mar 14, 2025 | $11.0K | +22.2% | 60.0% | -$5.7M | -$5.5M |
| Dec 2023filed Mar 22, 2024 | $9.0K | -89.8% | 60.0% | -$5.6M | -$5.3M |
| Dec 2022filed Mar 31, 2023 | $88.6K | +1.0% | 67.8% | -$10.2M | -$10.1M |
| Dec 2021filed Mar 30, 2022 | $87.8K | -46.7% | 45.4% | -$3.1M | $19.2M |
| Dec 2020filed Mar 17, 2021 | $164.5K | -0.6% | 69.2% | -$1.1M | -$36.3M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched CELZ. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
82,052 shares short
-82,730 shares (-50.2%) vs Sep 30, 2026
1.3% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
164,782 shares short
+80,526 shares (+95.6%) vs Sep 15, 2026
2.5% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
84,256 shares short
-188,556 shares (-69.1%) vs Aug 31, 2026
2.5% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
272,812 shares short
-311,797 shares (-53.3%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
584,609 shares short
+521,302 shares (+823.5%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
63,307 shares short
-12,956 shares (-17%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind CELZ’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
1 for 10 · reverse split
Effective Jun 12, 2023
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 500 · reverse split
Effective Nov 10, 2021
Each 500 pre-split shares become 1 post-split share.
Source: EODHD
1 for 150 · reverse split
Effective Feb 3, 2020
Each 150 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if CELZ is in your portfolio and how much it contributes.
Sign inLoading market dates
1 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
13 filers reported a long position in CELZ for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
99.8%
of the 372.6K shares 13-F filers reported
Moves vs Q1 2026
3 added1 trimmed
3 new · 2 unchanged · 1 not comparable
Net shares held
+5.7%
across the 6 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Hudson Bay Capital Management LP | $196K · 135.2K shares | 135.2K | New |
| 2 | Anson Funds Management LP | $153K · 105.5K shares | 105.5K | New |
| 3 | ARMISTICE CAPITAL, LLC | $60.9K · 42K shares | 42K | New |
| 4 | XTX Topco Ltd | $38.5K · 26.6K shares | 26.6K | +86.2% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $37.4K · 25.8K shares | 25.8K | -32.6% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $29.5K · 20.4K shares | 20.4K | Unchanged |
| 7 | VANGUARD FIDUCIARY TRUST CO | $8K · 5.5K shares | 5.5K | Unchanged |
| 8 | Tower Research Capital LLC (TRC) | $7K · 4.9K shares | 4.9K | +132% |
| 9 | Global Retirement Partners, LLC | $6K · 4.1K shares | 4.1K | — |
| 10 | UBS Group AG | $3K · 2.1K shares | 2.1K | +206,000% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of CELZ file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Oct 1, 2026 | Warbington Timothy13D · activist | 13.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.